Issued Patents All Time
Showing 26–50 of 81 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10544110 | Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer | James K. Johnson, Erin M. Skoda, Joel B. Nelson, Zhou Wang | 2020-01-28 |
| 10526280 | (2-amino-4-(arylamino)phenyl carbamates | Athanassios Tzounopoulos | 2020-01-07 |
| 10526368 | Targeted nitroxide agents | Marie-Celine Frantz | 2020-01-07 |
| 10478437 | Combination therapy to enhance the anticancer efficacy of platinum drugs | Wei Qian, Bennett Van Houten | 2019-11-19 |
| 10450289 | Substituted β-lapachones for treating cancer | Bennett Van Houten, Wei Qian, Chaemin Lim | 2019-10-22 |
| 10308663 | Inhibitors of PTP4A3 for the treatment of cancer | John S. Lazo, Elizabeth Sharlow, Kelley E. McQueeney, Joseph M. Salamoun | 2019-06-04 |
| 10300083 | TLR4 inhibitors for the treatment of human infectious and inflammatory disorders | Matthew D. Neal, Sodhi P. Chhinder, David J. Hackam | 2019-05-28 |
| 10251860 | Compounds for bone healing | Michael W. Epperly, Joel S. Greenberger, Julianne Glowacki | 2019-04-09 |
| 10174031 | Calcium channel agonists | Stephen D. Meriney, Mary Liang | 2019-01-08 |
| 10172795 | Formulations and carrier systems including compound interactive domains | Xiang Gao, Song Li, Michael W. Epperly, Joel S. Greenberger | 2019-01-08 |
| 10004730 | Small molecules targeting androgen receptor nuclear localization and/or level in prostate cancer | Zhou Wang, Joel B. Nelson, Minh B. Nguyen, John S. Lazo, Paul A. Johnston | 2018-06-26 |
| 9981974 | Small molecules targeting androgen receptor nuclear localization and/or level in prostate cancer | Zhou Wang, Joel B. Nelson, Minh B. Nguyen, John S. Lazo, Paul A. Johnston | 2018-05-29 |
| 9938250 | Antifibrotic effects of oxetanyl sulfoxides | Carol A. Feghali-Bostwick | 2018-04-10 |
| 9890192 | Targeted nitroxide agents | Marie-Celine Frantz | 2018-02-13 |
| 9840515 | Protein kinase D inhibitors | Qiming Jane Wang | 2017-12-12 |
| 9796681 | Tetrahydroisoquinolines as selective NADPH oxidase 2 inhibitors | Patrick J. Pagano, Maria E. Cifuentes-Pagano, Erin M. Skoda | 2017-10-24 |
| 9796714 | Calcium channel agonists | Stephen D. Meriney, Mary Liang | 2017-10-24 |
| 9732105 | Targeted nitroxide agents | Marie-Celine Frantz | 2017-08-15 |
| 9708276 | Small molecules targeting androgen receptor nuclear localization and/or level in prostate cancer | Zhou Wang, Joel B. Nelson, Minh Mindy Bao Nguyen, John S. Lazo, Paul A. Johnston | 2017-07-18 |
| 9675446 | Prosthetic implant for medialization thyroplasty | James J. Jaber, Steven Charous, Christopher J. Siviy, April J. Chambers | 2017-06-13 |
| 9676738 | Antifibrotic effects of oxetanyl sulfoxides | Carol A. Feghali-Bostwick | 2017-06-13 |
| 9546144 | Bifunctional compounds | Joel S. Greenberger, Michael W. Epperly, Melissa M. Sprachman, Julie Pamela Goff | 2017-01-17 |
| 9532999 | TLR4 inhibitors for the treatment of human infectious and inflammatory disorders | Matthew D. Neal, Sodhi P. Chhinder, David J. Hackam | 2017-01-03 |
| 9402839 | Selective targeting agents for mitochondria | Jingbo Xiao, Mitchell P. Fink, Valerian Kagan, Yulia Y. Tyurina, Anthony J. Kanai | 2016-08-02 |
| 9220711 | Compounds for the treatment of pathologies associated with aging and degenerative disorders | Laura J. Niedernhofer, Paul D. Robbins | 2015-12-29 |